Leyton Connect 2026: Where Life Sciences Leaders Meet Innovation

Related Expertise:

Duration
2 min read
Published

Table of contents

Most Favoured Nations (MFN): What You Need to Know

An exclusive evening bringing together life sciences professionals, industry leaders and innovators to explore the evolving Canadian healthcare and pharmaceutical landscape.

DECEMBER 3, 2026 5:30 PM – 8:30 PM EST

LEYTON OFFICES 460 Rue McGill, 2nd Floor, Montréal, QC

IN PARTNERSHIP WITH WOMEN IN BIO / HBA MONTRÉAL

Understanding the Future of Life Sciences in Canada

The life sciences industry is evolving rapidly, bringing new opportunities, challenges and strategic considerations for organizations operating in Canada.

Join Leyton and Women in Bio / HBA Montréal for an exclusive evening of expert insights, meaningful discussions and high-value networking.

Explore the latest developments shaping the Canadian life sciences ecosystem, from clinical trials and R&D innovation funding to pharmaceutical market access.

Hear directly from industry experts, exchange perspectives with fellow professionals and discover how organizations can navigate the evolving Canadian healthcare and pharmaceutical landscape.

Whether you are driving innovation, developing new therapies or shaping market access strategies, this event will provide valuable insights to help you move forward.

One evening. Three key topics. Endless opportunities to connect.

Three Key Topics. One Evolving Industry.

Discover the opportunities, challenges and strategic considerations shaping the future of life sciences in Canada.

1

Navigating Market Access Opportunities in Canada: Understanding reimbursement pathways, pricing strategies and the key challenges of bringing pharmaceutical products to the Canadian market.

2

Unlocking R&D and Innovation Funding: Exploring tax incentives, government funding programs and financial opportunities to support research, development and innovation in Canada's life sciences sector.

3

Advancing Clinical Trials in Canada: Discovering Canada's clinical research landscape, its regulatory environment and the opportunities and challenges of conducting clinical trials.

Speakers

Vincent Joly

Sr Director, Business Development & Market Access, AVIR Pharma

Laurent Lecanu

Head of Life Science Cluster North America - Leyton

John Norman

Partner, None Listed

Sophie Rochon

Vice President Access, Policy and Patient Experience, Otsuka America Pharmaceutical, Inc

Isabelle Trempe

Chief Executive Officer

Ready for the next step?

Book a Free Assessment

Ready to accelerate your transformation? Schedule a 30-minute scoping session with one of our specialized partners to discuss your current challenges.